Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ENDRA Life Sciences (NDRA) Capital Expenditures (2018 - 2025)

ENDRA Life Sciences has reported Capital Expenditures over the past 4 years, most recently at $45000.0 for Q1 2021.

  • Quarterly Capital Expenditures rose 101.34% to $45000.0 in Q1 2021 from the year-ago period, while the trailing twelve-month figure was $45000.0 through Dec 2021, down 40.27% year-over-year, with the annual reading at $17280.0 for FY2025, 8.0% up from the prior year.
  • Capital Expenditures was $45000.0 for Q1 2021 at ENDRA Life Sciences, down from $64850.0 in the prior quarter.
  • Over five years, Capital Expenditures peaked at $100000.0 in Q3 2018 and troughed at -$11867.0 in Q3 2020.
  • The 4-year median for Capital Expenditures is $30353.5 (2019), against an average of $32991.0.
  • The largest YoY upside for Capital Expenditures was 326.61% in 2020 against a maximum downside of 69.07% in 2020.
  • A 4-year view of Capital Expenditures shows it stood at $100000.0 in 2018, then crashed by 61.64% to $38357.0 in 2019, then skyrocketed by 69.07% to $64850.0 in 2020, then plummeted by 30.61% to $45000.0 in 2021.
  • Per Business Quant, the three most recent readings for NDRA's Capital Expenditures are $45000.0 (Q1 2021), $64850.0 (Q4 2020), and -$11867.0 (Q3 2020).